|
1
|
Gehrig PA and Bae-Jump VL: Promising novel
therapies for the treatment of endometrial cancer. Gynecol Oncol.
116:187–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang F, Liu T, He Y, et al: MiR-125b
promotes proliferation and migration of type II endometrial
carcinoma cells through targeting TP53INP1 tumor suppressor in
vitro and in vivo. BMC Cancer. 11:4252011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marx J: Cancer research. Mutant stem cells
may seed cancer. Science. 301:1308–1310. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang S, Balch C, Chan MW, et al:
Identification and characterization of ovarian cancer-initiating
cells from primary human tumors. Cancer Res. 68:4311–4320. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mayol JF, Loeuillet C, Herodin F and Wion
D: Characterisation of normal and cancer stem cells: one
experimental paradigm for two kinds of stem cells. Bioessays.
31:993–1001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu T, Xu F, Du X, et al: Establishment
and characterization of multi-drug resistant, prostate
carcinoma-initiating stem-like cells from human prostate cancer
cell lines 22RV1. Mol Cell Biochem. 340:265–273. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma L, Lai D, Liu T, Cheng W and Guo L:
Cancer stem-like cells can be isolated with drug selection in human
ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin
(Shanghai). 42:593–602. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu T, Cheng W, Lai D, Huang Y and Guo L:
Characterization of primary ovarian cancer cells in different
culture systems. Oncol Rep. 23:1277–1284. 2010.PubMed/NCBI
|
|
14
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dalerba P, Dylla SJ, Park IK, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
17
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lapidot T, Sirard C, Vormoor J, et al: A
cell initiating human acute myeloid leukaemia after transplantation
into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Monzani E, Facchetti F, Galmozzi E, et al:
Melanoma contains CD133 and ABCG2 positive cells with enhanced
tumourigenic potential. Eur J Cancer. 43:935–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eramo A, Lotti F, Sette G, et al:
Identification and expansion of the tumorigenic lung cancer stem
cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dou J, Pan M, Wen P, et al: Isolation and
identification of cancer stem-like cells from murine melanoma cell
lines. Cell Mol Immunol. 4:467–472. 2007.PubMed/NCBI
|
|
23
|
Gupta RA, Shah N, Wang KC, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zöller M: CD44: can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011.PubMed/NCBI
|
